Index of reports
> Death (37)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to MS Contin (Morphine) death. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 37 Next >>
Possible MS Contin side effects in 38 year old male
Reported by a consumer/non-health professional from Australia on 2012-06-27
Patient: 38 year old male, weighing 149.0 kg (327.8 pounds)
Reactions: Fatigue, Snoring, Arteriosclerosis Coronary Artery, Toxicity To Various Agents, Drug Abuse, Cardiomegaly, Hepatic Steatosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Diazepam
Dosage: unk
Indication: Back Pain
MS Contin
Dosage: 160 mg, 1x/day
Clonazepam
Indication: Anxiety
MS Contin
Dosage: 100 mg, 1x/day
Indication: Pain
Diazepam
Indication: Anxiety
Alprazolam
Dosage: unk
Indication: Back Pain
Alprazolam
Indication: Agitation
Clonazepam
Indication: Agitation
Clonazepam
Dosage: unk
Indication: Back Pain
Alprazolam
Indication: Anxiety
Diazepam
Indication: Agitation
Other drugs received by patient: Codeine; Zuclopenthixol; Metoclopramide
Possible MS Contin side effects in 38 year old male
Reported by a physician from Australia on 2012-06-26
Patient: 38 year old male, weighing 149.0 kg (327.8 pounds)
Reactions: Fatigue, Snoring, Arteriosclerosis Coronary Artery, Toxicity To Various Agents, Drug Abuse, Cardiomegaly, Hepatic Steatosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Alprazolam
Indication: Agitation
Clonazepam
Indication: Back Pain
Alprazolam
Dosage: unk
Indication: Back Pain
Diazepam
Indication: Agitation
Alprazolam
Indication: Anxiety
MS Contin
Dosage: 100 mg, 1x/day
Indication: Pain
Clonazepam
Indication: Agitation
Diazepam
Indication: Back Pain
Clonazepam
Indication: Anxiety
MS Contin
Dosage: 160 mg, 1x/day
Diazepam
Indication: Anxiety
Other drugs received by patient: Zuclopenthixol; Metoclopramide; Codeine
Possible MS Contin side effects in 79 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-15
Patient: 79 year old male
Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Possible MS Contin side effects in 79 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14
Patient: 79 year old male
Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Possible MS Contin side effects in 79 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-12
Patient: 79 year old male
Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Possible MS Contin side effects in male
Reported by a physician from United States on 2012-05-17
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
MS Contin
Dosage: 900 mg, unk
MS Contin
Dosage: 600 mg, unk
Possible MS Contin side effects in male
Reported by a physician from United States on 2012-05-15
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
MS Contin
Possible MS Contin side effects in 83 year old female
Reported by a physician from Canada on 2012-05-03
Patient: 83 year old female
Reactions: Drug Administration Error, Accidental Exposure
Adverse event resulted in: death
Drug(s) suspected as cause:
MS Contin
Possible MS Contin side effects in male
Reported by a physician from United States on 2012-04-16
Patient: male
Reactions: Confusional State, Prostate Cancer Metastatic, Multiple Drug Overdose, Respiratory Depression, Drug Abuse
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Dosage: 100 mg, 2x/day
Administration route: Oral
Indication: Pain
Start date: 2011-02-01
Morphine Sulfate
Dosage: 30 mg, every 4-6 hours as needed
Administration route: Oral
Indication: Pain
Start date: 2011-02-01
Possible MS Contin side effects in
Reported by a pharmacist from United States on 2012-04-13
Patient:
Reactions: Weight Decreased, Abdominal Pain, Dyspnoea, Nausea, Fatigue, Dyspnoea Exertional, Syncope, Pancreatic Carcinoma Metastatic, Liver Function Test Abnormal, Dehydration, Oedema
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Tracleer
Dosage: 125 mg, bid
Administration route: Oral
Start date: 2012-03-08
End date: 2012-03-28
Tracleer
Dosage: 125 mg, bid
Administration route: Oral
End date: 2012-01-01
Tracleer
Dosage: 62.5 mg, bid
Administration route: Oral
Indication: Pulmonary Arterial Hypertension
Start date: 2008-02-21
Tracleer
Dosage: 62.5 mg, bid
Administration route: Oral
Start date: 2012-01-01
End date: 2012-03-07
MS Contin
Other drugs received by patient: Aspirin; Plavix; Sucralfate; Nitroglycerin; Gemcitabine; Mycophenolate Mofetil (Cellcept); Mupirocin; Ambien; Lexapro; Zofran
Possible MS Contin side effects in male
Reported by a physician from United States on 2012-04-11
Patient: male
Reactions: Confusional State, Prostate Cancer Metastatic, Respiratory Depression, Multiple Drug Overdose, Drug Abuse
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Dosage: 100 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2011-02-01
Morphine Sulfate
Dosage: 30 mg, q4- 6h prn
Administration route: Oral
Indication: Pain
Start date: 2011-02-01
Possible MS Contin side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-02
Patient: female
Reactions: Pulmonary Hypertension, Biliary Tract Operation, Drug Ineffective, Pancreatic Neoplasm, Death, Hepatic Encephalopathy, Oesophagitis, Cholangitis, Pancreatitis Chronic, Gastrooesophageal Reflux Disease, Renal Failure Acute, Dysphagia, Metabolic Acidosis, Type 2 Diabetes Mellitus, Hypotension, Renal Failure Chronic, Cerebrovascular Accident, Hyperlipidaemia, Diarrhoea, Liver Transplant Rejection, Feeling Abnormal, Hypertension, Herpes Virus Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Dosage: unk
Indication: Pain
Prograf
Dosage: 0.5 unk, q3d
Start date: 2012-01-01
End date: 2012-01-29
Prograf
Dosage: 0.5 mg, bid
Administration route: Oral
Indication: Liver Transplant
Start date: 1997-07-08
End date: 2012-01-01
Lactulose
Dosage: unk
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Diflucan; Sodium Bicarbonate; Carafate; Morphine; Oxycodone HCL; Xifaxan; MAG-OX; Protonix; Insulin; Creon; Metoprolol Succinate
Possible MS Contin side effects in 53 year old male
Reported by a physician from China on 2012-03-28
Patient: 53 year old male
Reactions: Respiratory Depression
Adverse event resulted in: death
Drug(s) suspected as cause:
MS Contin
Possible MS Contin side effects in 79 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-21
Patient: 79 year old male
Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Possible MS Contin side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-19
Patient: female
Reactions: Pulmonary Hypertension, Biliary Tract Operation, Drug Ineffective, Pancreatic Neoplasm, Death, Hepatic Encephalopathy, Oesophagitis, Cholangitis, Pancreatitis Chronic, Gastrooesophageal Reflux Disease, Renal Failure Acute, Type 2 Diabetes Mellitus, Dysphagia, Metabolic Acidosis, Hypotension, Renal Failure Chronic, Cerebrovascular Accident, Hyperlipidaemia, Diarrhoea, Liver Transplant Rejection, Hypertension, Feeling Abnormal, Herpes Virus Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Prograf
Dosage: 0.5 unk, q3d
Start date: 2012-01-01
End date: 2012-01-29
Prograf
Dosage: 0.5 mg, bid
Administration route: Oral
Indication: Liver Transplant
Start date: 1997-07-08
End date: 2012-01-01
Lactulose
Dosage: unk
Indication: Product Used FOR Unknown Indication
MS Contin
Dosage: unk
Indication: Pain
Other drugs received by patient: Morphine; Oxycodone HCL; Metoprolol Succinate; Creon; Xifaxan; Protonix; Sodium Bicarbonate; Insulin; MAG-OX; Diflucan; Carafate
Possible MS Contin side effects in 79 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-15
Patient: 79 year old male
Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Possible MS Contin side effects in
Reported by a physician from Canada on 2012-03-15
Patient:
Reactions: Overdose, Drug Prescribing Error
Adverse event resulted in: death
Drug(s) suspected as cause:
MS Contin
Possible MS Contin side effects in
Reported by a physician from Canada on 2012-03-12
Patient:
Reactions: Overdose, Drug Prescribing Error
Adverse event resulted in: death
Drug(s) suspected as cause:
MS Contin
Possible MS Contin side effects in 79 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-12
Patient: 79 year old male
Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Possible MS Contin side effects in 76 year old male
Reported by a consumer/non-health professional from United States on 2012-03-09
Patient: 76 year old male, weighing 123.0 kg (270.6 pounds)
Reactions: Dyspnoea, Pleuritic Pain, Lung Infection, Lymphopenia, Hyponatraemia, Anxiety, Fatigue, Dehydration, Neutropenia, Thrombocytopenia, Leukopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Fentanyl-100
MS Contin
Taxol
Dosage: last adminstered dose:7dec11,462mg on 17jan12
Indication: non-Small Cell Lung Cancer
Start date: 2011-11-15
End date: 2012-01-17
Carboplatin
Dosage: last administered dose:7dec11,691mg on 17jan12
Indication: non-Small Cell Lung Cancer
Start date: 2011-11-15
End date: 2012-01-17
Possible MS Contin side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-07
Patient: 65 year old male
Reactions: Abdominal Pain, Large Intestine Perforation, Nausea, Lung Cancer Metastatic, Constipation, Infectious Peritonitis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Dalteparin Sodium
Dosage: unk
Indication: Lung Neoplasm Malignant
Start date: 2010-12-20
End date: 2011-02-25
Aprepitant
Dosage: unk
Start date: 2011-02-25
End date: 2011-02-25
Dexamethasone
Dosage: 4 mg, unk
Administration route: Oral
End date: 2011-02-25
Cisplatin
Dosage: unk
Start date: 2010-12-21
End date: 2011-02-25
Ondansetron
Dosage: 8 mg, unk
Administration route: Oral
MS Contin
Dosage: 30 mg, unk
Administration route: Oral
Pemetrexed Disodium
Dosage: unk
Start date: 2010-12-21
End date: 2011-02-25
Other drugs received by patient: Acetaminophen; Piperacillin and Tazobactam
Possible MS Contin side effects in 76 year old male
Reported by a consumer/non-health professional from United States on 2012-03-06
Patient: 76 year old male, weighing 123.0 kg (270.6 pounds)
Reactions: Anxiety, Fatigue, Dyspnoea, Pleuritic Pain, Dehydration, Lung Infection, Lymphopenia, Hyponatraemia, Neutropenia, Thrombocytopenia, Leukopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Fentanyl-100
Taxol
Dosage: last adminstered dose:7dec11,462mg on 17jan12
Indication: non-Small Cell Lung Cancer
Start date: 2011-11-15
End date: 2012-01-17
MS Contin
Carboplatin
Dosage: last administered dose:7dec11,691mg on 17jan12
Indication: non-Small Cell Lung Cancer
Start date: 2011-11-15
End date: 2012-01-17
Possible MS Contin side effects in 84 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-01-31
Patient: 84 year old female
Reactions: Wrong Drug Administered, Product Label Confusion
Adverse event resulted in: death
Drug(s) suspected as cause:
MS Contin
Dosage: 60 mg, unk
Administration route: Oral
Darvon-N
Administration route: Oral
Possible MS Contin side effects in 84 year old female
Reported by a consumer/non-health professional from Canada on 2012-01-27
Patient: 84 year old female
Reactions: Wrong Drug Administered, Product Label Confusion
Adverse event resulted in: death
Drug(s) suspected as cause:
MS Contin
Dosage: 60 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Darvon-N
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible MS Contin side effects in male
Reported by a physician from United States on 2012-01-05
Patient: male, weighing 48.7 kg (107.1 pounds)
Reactions: Abdominal Pain Lower, Hypoglycaemia, General Physical Health Deterioration, Loss of Consciousness
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Bevacizumab (Rhumab Vegf)
Dosage: 224 mg
End date: 2011-11-22
Leucovorin Calcium
Dosage: 655 mg
Fluorouracil
Dosage: 3585 mg
End date: 2011-11-22
Irinotecan HCL
Dosage: 229 mg
End date: 2011-11-22
Other drugs received by patient: Princess Margaret Hosp. Mouthwash; Senokot; Betamethasone; Granisetron; Colace; Gabepentin; Decadron; Stemetil; Fentanyl-100; Lactulase; Simvastatin
Possible MS Contin side effects in male
Reported by a physician from United Kingdom on 2011-12-22
Patient: male, weighing 69.0 kg (151.8 pounds)
Reactions: Respiratory Arrest, Toxicity To Various Agents, Epilepsy, Accidental Overdose
Adverse event resulted in: death
Drug(s) suspected as cause:
MS Contin
Dosage: 20 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2006-01-17
Morphine Sulfate
Dosage: 80 mg, daily
Administration route: Oral
Indication: Pain
Clobazam
Dosage: 20 mg, bid
Indication: Convulsion
Other drugs received by patient: Trileptal; Buprenorphine; Benzodiazepine Derivatives; Epanutin / 00017401 /; Prozac; Zanaflex; Temazepam
Possible MS Contin side effects in 32 year old male
Reported by a physician from United Kingdom on 2011-12-21
Patient: 32 year old male, weighing 69.0 kg (151.8 pounds)
Reactions: Respiratory Arrest, Toxicity To Various Agents, Accidental Overdose, Epilepsy
Adverse event resulted in: death
Drug(s) suspected as cause:
MS Contin
Dosage: 20 mg, 2x/day
Administration route: Oral
Indication: Pain
Start date: 2006-01-17
Morphine Sulfate
Dosage: 80 mg, daily
Administration route: Oral
Indication: Pain
Clobazam
Dosage: 20 mg, 2x/day
Indication: Convulsion
Other drugs received by patient: Buprenorphine; Trileptal; Zanaflex; Prozac; Temazepam; Phenytoin Sodium
Possible MS Contin side effects in 40 year old male
Reported by a physician from Hungary on 2011-12-08
Patient: 40 year old male
Reactions: Weight Decreased, Jaundice, Anaemia, Hypotension, Coma, Neoplasm Progression, Disorientation, Hepatic Enzyme Increased, Convulsion, Therapeutic Response Decreased, Urinary Retention, Hallucination
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Morphine
Indication: Cancer Pain
MS Contin
Administration route: Oral
Fentanyl-100
End date: 2010-10-01
MS Contin
Administration route: Oral
Indication: Cancer Pain
Fentanyl-100
End date: 2010-04-01
Fentanyl-100
Fentanyl-100
Nsaid
Indication: Pain
MS Contin
Administration route: Oral
Amitriptyline HCL
Indication: Pain
MS Contin
Administration route: Oral
Hydromorphone HCL
Indication: Cancer Pain
Start date: 2010-04-01
End date: 2010-06-01
Fentanyl-100
Indication: Cancer Pain
Fentanyl-100
Start date: 2010-06-01
Gemcitabine
Indication: Chemotherapy
Cisplatin
Indication: Chemotherapy
Possible MS Contin side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-23
Patient: male
Reactions: Neoplasm Malignant
Adverse event resulted in: death
Drug(s) suspected as cause:
MS Contin
Norco
Indication: Neoplasm Malignant
Possible MS Contin side effects in 40 year old male
Reported by a physician from Hungary on 2011-11-18
Patient: 40 year old male
Reactions: Jaundice, Weight Decreased, Hypotension, Anaemia, Neoplasm Progression, Coma, Disorientation, Hepatic Enzyme Increased, Convulsion, Therapeutic Response Decreased, Urinary Retention, Hallucination
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Hydromorphone HCL
Indication: Cancer Pain
Start date: 2010-04-01
End date: 2010-06-01
Fentanyl-100
Gemcitabine
Indication: Chemotherapy
Cisplatin
Indication: Chemotherapy
Fentanyl-100
Indication: Cancer Pain
Fentanyl-100
End date: 2010-10-01
Morphine
Indication: Cancer Pain
Amitriptyline HCL
Indication: Pain
Nsaid
Indication: Pain
MS Contin
Administration route: Oral
MS Contin
Administration route: Oral
Fentanyl-100
Fentanyl-100
Start date: 2010-06-01
MS Contin
Administration route: Oral
Fentanyl-100
End date: 2010-04-01
MS Contin
Administration route: Oral
Indication: Cancer Pain
Page 1 Next >>
|